|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
3779479 |
| 003 |
ICU |
| 005 |
20030527192700.0 |
| 008 |
970210s1997 pau 000 0 eng d |
| 010 |
|
|
|a gb 98007141
|
| 015 |
|
|
|a GB98-7141
|
| 020 |
|
|
|a 0397584431
|
| 035 |
|
|
|a (OCoLC)36363074
|
| 040 |
|
|
|a SWT
|c SWT
|d UKM
|d OCL
|d OrLoB-B
|d OCoLC
|
| 049 |
|
|
|a CGUA
|
| 060 |
|
|
|a QZ 267
|b In8a 1997
|
| 111 |
2 |
|
|a International Conference on the Adjuvant Therapy of Cancer
|n (8th :
|d 1996 :
|c Scottsdale, Ariz.)
|
| 245 |
1 |
0 |
|a Adjuvant therapy of cancer VIII :
|b proceedings of the Eighth International Conference on the Adjuvant Therapy of Cancer, Scottsdale, Arizona, March, 1996 /
|c edited by Sydney E. Salmon.
|
| 260 |
|
|
|a Philadelphia :
|b Lippincott,
|c c1997.
|
| 300 |
|
|
|a xviii, 298 p. ;
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 500 |
|
|
|a Eighth conference held March 13-16, 1996.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
0 |
|g 1.
|t Adjuvant Therapy of Cancer: Past, Present, and Future /
|r Sydney E. Salmon --
|g 2.
|t Gene Transfer into Tumor Cells In Vitro and In Vivo: Potential for Adjuvant Therapy of Cancer /
|r Alison T. Stopeck and Evan M. Hersh --
|g 3.
|t Development of RMP-7: A Novel Bradykinin Agonist That Increases Delivery of Chemotherapeutics to Gliomas /
|r John J. Grous, Peter J. Elliott and Raymond T. Bartus --
|g 4.
|t Late Effects of Adjuvant Chemotherapy for the Treatment of Cancer in Children and Adolescents /
|r Daniel M. Green --
|g 5.
|t Use and Coverage of Novel Cancer Agents in Managed Care /
|r Joseph S. Bailes --
|g 6.
|t Advances in the Biological Study, Prevention, and Therapy of Head and Neck Cancer /
|r E. H. Bernicker, F. R. Khuri and S. M. Lippman [et al.] --
|g 7.
|t Adjuvant Chemotherapy of Non-Small-Cell Lung Cancer /
|r Olivier Rixe and Thierry Le Chevalier --
|g 8.
|t Update of the Milan Cancer Institute Studies in Operable Breast Cancer /
|r Gianni Bonadonna, Pinuccia Valagussa and Angela Moliterni [et al.] --
|g 9.
|t Recent Findings from Three NSABP Clinical Trials Evaluating Systemic Adjuvant Therapy in Patients with Primary Breast Cancer and Negative Axillary Nodes /
|r Bernard Fisher and James Dignam --
|g 10.
|t Impact of FAC-Adjuvant Therapy on Mortality of Early Breast Cancer: Long-Term Results of the M. D. Anderson Cancer Center Studies /
|r Aman U. Buzdar, Gabriel N. Hortobagyi and S. Eva Singletary [et al.] --
|g 11.
|t CMF Versus Tamoxifen Plus Goserelin as Adjuvant Treatment of ER-Positive Pre-Perimenopausal Breast Cancer Patients: Preliminary Results of an Ongoing Italian Breast Cancer Adjuvant Study Group (GROCTA) Trial /
|r F. Boccardo, A. Rubagotti and D. Amoroso [et al.] --
|g 12.
|t High-Dose Chemotherapy with Stem Cell Protection: Tandem, Sequence, and Phenylalanine Mustard Studies /
|r Emil Frei III, J. Bitran and L. Ayash [et al.] --
|g 13.
|t High-Dose Chemotherapy for High-Risk Primary Breast Cancer /
|r William P. Peters, Roger Dansey and Jared Klein [et al.] --
|g 14.
|t High-Dose-Intensity Doxorubicin-Cyclophosphamide with rh-GCSF and Peripheral Blood Stem Cells: Outpatient Adjuvant Treatment for Premenopausal Patients with Breast Carcinoma /
|r P. Viens, D. Genre and G. Gravis [et al.] --
|g 15.
|t Breast Cancer, Surgery, and the Menstrual Cycle /
|r William J. M. Hrushesky --
|g 16.
|t Rationale for Combined Antiestrogen-Somatostatin Analogue Therapy of Breast Cancer /
|r M. Pollak, J. Ingle and V. Suman [et al.] --
|g 17.
|t Clodronate as an Adjuvant to Hormone and Chemotherapy in Patients with Breast Cancer /
|r Alexander H. G. Paterson, John A. Kanis and Trevor Powles [et al.] --
|g 18.
|t Breast Cancer Roundtable /
|r Emil Frei III, Karen Antman and Bernard Fisher [et al.] --
|g 19.
|t Adjuvant Therapy of Upper Gastrointestinal Tract Cancers /
|r David Kelsen --
|g 20.
|t Adjuvant Therapy for Carcinoma of the Colon and Rectum: Review of the NSABP Clinical Trials /
|r Norman H. Wolmark and Bernard Fisher --
|g 21.
|t 5-Fluorouracil Plus Levamisole with or without 6-S-Leucovorin as Adjuvant Treatment of Resected Colon Cancer /
|r The INTACC --
|g 22.
|t A Prospective Comparison of Fluorouracil/Folinic Acid versus Levamisole/Fluorouracil as Adjuvant Therapy after Resection of Stage III Colon Carcinoma /
|r Alfred Wong and Alexander Chan --
|g 23.
|t Adjuvant Therapy of Ovarian Cancer - Is There Reason for Optimism? /
|r David S. Alberts and Dava J. Garcia --
|g 24.
|t A Review of the Neoadjuvant and Adjuvant Treatment of Prostate Cancer /
|r Frederick R. Ahmann --
|g 25.
|t Adjuvant Trials in Bladder Cancer: Scientific Background, Review, and New Directions /
|r R. T. D. Oliver and C. Boshoff --
|g 26.
|t Adjuvant Concepts in Testicular Cancer /
|r Lawrence H. Einhorn --
|g 27.
|t CHOP Plus Radiotherapy Is Superior to CHOP Alone for Adjuvant Therapy of Resected Localized Unfavorable Non-Hodgkin's Lymphoma: A Southwest Oncology Group Study /
|r Thomas P. Miller, Steve Dahlberg and James R. Cassady [et al.] --
|g 28.
|t Adjuvant Therapy of High-Risk Melanoma: The Role of High-Dose Interferon [alpha]-2b /
|r John M. Kirkwood, Myla Hunt Strawderman and Marc S. Ernstoff [et al.] --
|g 29.
|t Is Interferon-[gamma] Detrimental? Results of a Southwest Oncology Group Randomized Trial of Adjuvant Interferon-[gamma] versus Observation in Melanoma /
|r Venon K. Sondak, Kenneth J. Kopecky and John W. Smith II [et al.] --
|g 30.
|t The Recent Experience at the Rizzoli Institute in the Treatment of Osteosarcoma /
|r P. Picci, G. Bacci and S. Ferrari [et al.] --
|g 31.
|t Adjuvant Therapy of Sarcomas of Bone and Soft Tissue /
|r Karen H. Antman --
|g 32.
|t Adjuvant Therapy of Cancer VIII: Concluding Perspectives /
|r Anne Schott and Laurence H. Baker.
|
| 650 |
|
2 |
|a Adjuvants, Immunologic
|x therapeutic use
|v Congresses.
|
| 650 |
|
2 |
|a Adjuvants, Pharmaceutic
|x therapeutic use
|v Congresses.
|
| 650 |
|
2 |
|a Neoplasms
|x drug therapy
|v congresses.
|
| 650 |
|
0 |
|a Cancer
|x Adjuvant treatment
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2008005053
|
| 650 |
|
7 |
|a Cancer
|x Adjuvant treatment.
|2 fast
|0 http://id.worldcat.org/fast/fst00845318
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
|
|a Salmon, S. E.
|q (Sydney E.),
|d 1936-
|0 http://id.loc.gov/authorities/names/n79034800
|1 http://viaf.org/viaf/2534290
|
| 740 |
0 |
|
|a Adjuvant therapy of cancer eight.
|
| 740 |
0 |
|
|a Adjuvant therapy of cancer 8.
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i fccde2aa-4046-5754-8aee-7615434b60a9
|s 84950793-d17d-5c08-bde2-b1b0c2518a45
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.A35I571 1996
|l ASR
|c ASR-SciASR
|i 3898300
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.A35I571 1996
|l ASR
|c ASR-SciASR
|e CRERAR
|b 50682125
|i 6214851
|
